Example: confidence
Flixabi - European Medicines Agency
How does Flixabi work? The active substance in Flixabi, infliximab , is a monoclonal antibody (a type of protein) that has been designed to attach to a protein called tumour necrosis factor -alpha (TNF-alpha) and block its activity.
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
REMICADE - Janssen
www.janssen.comREMICADE ® 2 . Before you are given REMICADE . When you must not be given it . Do not use REMICADE if you have an allergy to mouse proteins or any of the ingredients listed at
Guide to Human CD antigens
docs.abcam.comAbout Abcam Abcam is a provider of protein research tools and services, with an unrivaled range of products and expert technical support, enabling scientists to analyze living cells
Apoptosis - Abcam
docs.abcam.com5 Apoptosis Apoptosis is a type of programmed cell death that is critical for numerous normal physiological processes . Historically, apoptosis has been defined by its morphological
Anatomy and Physiology of Peritoneal Dialysis
ispd.orgOutline • Peritoneal cavity as a dialysis system • Models of peritoneal transport • Physiology of peritoneal transport Inverse relationship between solute transport and ultrafiltration • …
Sample Quantitative Research Proposal Published by ...
www.akamaiuniversity.us1 Sample Quantitative Research Proposal Published by Permission of the Author Dissertation Proposal Christina Ross PhD(c) Topic: Energy Medicine INTRODUCTION
Trypanosoma cruzi trans-Sialidase Prevents Elicitation of ...
www.biocombiotech.comArgentina / Argentina Trypanosoma cruzi trans-Sialidase Prevents Elicitation of Th1 Cell Response via Interleukin 10 and Downregulates Th1 Effector Cells
Original article: ANTI-INFLAMMATORY EFFECT AND …
www.excli.deEXCLI Journal 2017;16:1103-1113 – ISSN 1611-2156 Received: June 26, 2017, accepted: August 17, 2017, published: August 29, 2017 1103 Original article: ANTI-INFLAMMATORY EFFECT AND MECHANISM OF ACTION OF LINDERA ERYTHROCARPA ESSENTIAL OIL IN